Skip to main content

and
  1. Article

    Open Access

    Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada

    Every year, over 1 million people develop isoniazid (INH) resistant tuberculosis (TB). Yet, the optimal treatment regimen remains unclear. Given increasing prevalence, the clinical efficacy of regimens used by...

    Kamila Romanowski, Leslie Y. Chiang, David Z. Roth, Mel Krajden in BMC Infectious Diseases (2017)

  2. No Access

    Article

    Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings

    The risk of tuberculosis (TB) is variable among individuals with latent Mycobacterium tuberculosis infection (LTBI), but validated estimates of personalized risk are lacking. In pooled data from 18 systematically...

    Rishi K. Gupta, Claire J. Calderwood, Alexei Yavlinsky, Maria Krutikov in Nature Medicine (2020)

  3. Article

    Open Access

    Using a theory-informed approach to guide the initial development of a post-tuberculosis care package in British Columbia, Canada

    The importance of addressing the long-term needs of tuberculosis (TB) survivors is gaining increasing attention. One promising approach to improving post-TB care is implementing a post-TB care package. With a ...

    Kamila Romanowski, Victoria Jane Cook, Mark Gilbert in BMC Health Services Research (2023)